lobbying_activities: 3052100
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3052100 | 5bca2ba5-c5cf-4b6a-b650-db6e3c72864a | Q3 | KNIGHT CAPITOL CONSULTANTS | 40036301 | REGENXBIO | 2023 | third_quarter | PHA | Development of legislation that would affect the research, regulation or pricing of biopharmaceuticals, including implementation of the Inflation Reduction Act (no specific legislation) | SENATE | 60000 | 0 | 0 | 2023-10-16T22:53:51-04:00 |